Sydney School of Public Health, the University of Sydney, Sydney, Australia.
CMAJ. 2012 Mar 20;184(5):E277-83. doi: 10.1503/cmaj.111355. Epub 2012 Feb 6.
For every patient with chronic kidney disease who undergoes renal-replacement therapy, there is one patient who undergoes conservative management of their disease. We aimed to determine the most important characteristics of dialysis and the trade-offs patients were willing to make in choosing dialysis instead of conservative care.
We conducted a discrete choice experiment involving adults with stage 3-5 chronic kidney disease from eight renal clinics in Australia. We assessed the influence of treatment characteristics (life expectancy, number of visits to the hospital per week, ability to travel, time spent undergoing dialysis [i.e., time spent attached to a dialysis machine per treatment, measured in hours], time of day at which treatment occurred, availability of subsidized transport and flexibility of the treatment schedule) on patients' preferences for dialysis versus conservative care.
Of 151 patients invited to participate, 105 completed our survey. Patients were more likely to choose dialysis than conservative care if dialysis involved an increased average life expectancy (odds ratio [OR] 1.84, 95% confidence interval [CI] 1.57-2.15), if they were able to dialyse during the day or evening rather than during the day only (OR 8.95, 95% CI 4.46-17.97), and if subsidized transport was available (OR 1.55, 95% CI 1.24-1.95). Patients were less likely to choose dialysis over conservative care if an increase in the number of visits to hospital was required (OR 0.70, 95% CI 0.56-0.88) and if there were more restrictions on their ability to travel (OR=0.47, 95%CI 0.36-0.61). Patients were willing to forgo 7 months of life expectancy to reduce the number of required visits to hospital and 15 months of life expectancy to increase their ability to travel.
Patients approaching end-stage kidney disease are willing to trade considerable life expectancy to reduce the burden and restrictions imposed by dialysis.
对于每一位接受肾脏替代治疗的慢性肾脏病患者,都有一位接受疾病保守治疗的患者。我们旨在确定透析的最重要特征,以及患者在选择透析而不是保守治疗时愿意做出的权衡取舍。
我们进行了一项离散选择实验,涉及来自澳大利亚 8 个肾脏诊所的 3-5 期慢性肾脏病成人患者。我们评估了治疗特征(预期寿命、每周去医院的次数、旅行能力、每次透析时间(即每次治疗时连接到透析机的时间,以小时为单位)、治疗时间、补贴交通的可用性和治疗时间表的灵活性)对患者选择透析与保守治疗的偏好的影响。
在邀请参加的 151 名患者中,有 105 名完成了我们的调查。如果透析能延长平均预期寿命(优势比[OR]1.84,95%置信区间[CI]1.57-2.15),如果他们能够在白天或晚上而不是仅在白天透析(OR 8.95,95%CI 4.46-17.97),如果提供补贴交通(OR 1.55,95%CI 1.24-1.95),患者更有可能选择透析而不是保守治疗。如果需要增加去医院的次数(OR 0.70,95%CI 0.56-0.88),或者如果对他们的旅行能力有更多限制(OR=0.47,95%CI 0.36-0.61),患者更不可能选择透析而不是保守治疗。患者愿意放弃 7 个月的预期寿命来减少所需的去医院次数,并放弃 15 个月的预期寿命来增加旅行能力。
接近终末期肾病的患者愿意用相当大的预期寿命来换取透析带来的负担和限制的减少。